Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Barr

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Pharmacology|January 1, 1972
The use of physical and animal models to assess bioavailabilityW H Barr
Transplantation Proceedings|May 20, 1999
Cyclosporine: the case for expanding bioequivalence criteria to include measures of individual bioequivalence in relevant population subsetsW H Barr
Transplantation Proceedings|May 20, 1999
Scientific and professional concerns regarding product interchange and subsequent monitoring of cyclosporine and other critical dose drugsW H Barr
Pharmacotherapy|July 1, 1984
The once-daily theophylline controversyW H Barr
Journal of Pharmaceutical Sciences|July 1, 1977
Effect of sleep on bioavailability of tetracyclineJ Adir, W H Barr
Journal of Pharmaceutical Sciences|February 1, 1970
Intestinal drug absorption and metabolism. II. Kinetic aspects of intestinal glucuronide conjugationW H Barr, S Riegelman
Rational Drug Therapy|January 1, 1972
The basis for selection of the dosage form and source of a drugG Levy, W H Barr
Journal of Pharmaceutical Sciences|February 1, 1970
Intestinal drug absorption and metabolism. I. Comparison of methods and models to study physiological factors of in vitro and in vivo intestinal absorptionW H Barr, S Riegelman
Annals of Clinical Research|January 1, 1974
Evaluation of the clinical inequivalency of drug products of varying bioavailabilityW H Barr, J Adir
Pharmaceutical Research|July 1, 1998
Absorption of propranolol in humans following oral, jejunal, and ileal administrationA Buch, W H Barr
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Pharmacology|January 1, 1972
The use of physical and animal models to assess bioavailabilityW H Barr
Transplantation Proceedings|May 20, 1999
Cyclosporine: the case for expanding bioequivalence criteria to include measures of individual bioequivalence in relevant population subsetsW H Barr
Transplantation Proceedings|May 20, 1999
Scientific and professional concerns regarding product interchange and subsequent monitoring of cyclosporine and other critical dose drugsW H Barr
Pharmacotherapy|July 1, 1984
The once-daily theophylline controversyW H Barr
Journal of Pharmaceutical Sciences|July 1, 1977
Effect of sleep on bioavailability of tetracyclineJ Adir, W H Barr
Journal of Pharmaceutical Sciences|February 1, 1970
Intestinal drug absorption and metabolism. II. Kinetic aspects of intestinal glucuronide conjugationW H Barr, S Riegelman
Rational Drug Therapy|January 1, 1972
The basis for selection of the dosage form and source of a drugG Levy, W H Barr
Journal of Pharmaceutical Sciences|February 1, 1970
Intestinal drug absorption and metabolism. I. Comparison of methods and models to study physiological factors of in vitro and in vivo intestinal absorptionW H Barr, S Riegelman
Annals of Clinical Research|January 1, 1974
Evaluation of the clinical inequivalency of drug products of varying bioavailabilityW H Barr, J Adir
Pharmaceutical Research|July 1, 1998
Absorption of propranolol in humans following oral, jejunal, and ileal administrationA Buch, W H Barr
Pageof 6